About Us

Composition:
Nebol Tablets 5mg:
Each Film Coated Tablet Contains:
Nebivalol HCI eq. to Nebivolol 2.5mg
Nebivolol HCI eq. to Nebivolol 5mg
Nebivolol HCI eq. to Nebivolol 10mg

Discription:
Nebivolol Tablets contain nebivolol, a cardiovascular medicine belonging to the group of selective beta-blocking agents (ie. with a selective action or the cardiovascular system). It prevents increased heart rate, controls heart pumping strength. It also exerts a dilating action on blood vessels, which contributes as well to lower blood pressure. It is used to treat raised blood pressure (hypertension).
Nebivolo Tablet is also used to treat mild and moderate chronic heart failure in patients aged 70 or over, in addition to other therapies.
you must talk to a doctor if you do not feel better or if you feel worse.

Composition:
Jenval Tablets 10/160mg:
Each Film Coated Tablet Contains:
Amlodipine (as besylate);10mg
Valsartan160mg

Discription:
Amlodipine/velsertan combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calciun antagonist class and Amlodipine/valsartan combines two antihypertensive compounds, with complementary mechanisms to control Ivalsartan to the angiotensin II antagonist class of medicines. The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

Indications:
Treatment of essential hypertension.
Amlodipine/valsartan is indicated in adults whose blood pressure is not adequately controlled on amlodipine or
valsartan monotherapy.

Composition:
Jenval Tablets 5/160mg:
Each Film Coated Tablet Contains:
Amlodipine (as besylate);5mg
Valsartan160mg

Discription:
Amlodipine/velsertan combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calciun antagonist class and Amlodipine/valsartan combines two antihypertensive compounds, with complementary mechanisms to control Ivalsartan to the angiotensin II antagonist class of medicines. The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

Indications:
Treatment of essential hypertension.
Amlodipine/valsartan is indicated in adults whose blood pressure is not adéquately controlled on amlodipine or
valsartan monotherapy.

Composition:
Jenval Tablets 5/80mg:
Each Film Coated Tablet Contains:
Amlodipine (as besylate);5mg
Valsartan80mg

Discription:
Amlodipine/velsertan combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calciun antagonist class and Amlodipine/valsartan combines two antihypertensive compounds, with complementary mechanisms to control Ivalsartan to the angiotensin II antagonist class of medicines. The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone.

Indications:
Treatment of essential hypertension.
Amlodipine/valsartan is indicated in adults whose blood pressure is not adéquately controlled on amlodipine or
valsartan monotherapy.

Composition:
Jenglip-M Tablets 50/500mg
Each film coated tablet contains:
Sitagliptin (As phosphate Monohydrate):50mg
Metformin Hydrochloride: 500mg
Jenglip-M Tablets 50/1000mg
Each fllim coated tablet contains:
Sitagliptin (As phosphate Monohydrate):50mg
Metformin Hydrochloride 1000mg

Discription:
Jenglip-M combines two anthihyperglycaemic medicinal products with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: sitagliptin phosphate, a dipeptidyl peptidase 4 (DPP-4) ihibitor, and metformin hydrochloride, a member of the biguanide class.

Composition:
Jenglip-M Tablets 50/500mg
Each film coated tablet contains:
Sitagliptin (As phosphate Monohydrate):50mg
Metformin Hydrochloride: 500mg
Jenglip-M Tablets 50/1000mg
Each fllim coated tablet contains:
Sitagliptin (As phosphate Monohydrate):50mg
Metformin Hydrochloride 1000mg

Discription:
Jenglip-M combines two anthihyperglycaemic medicinal products with complementary mechanisms of action to improve glycaemic control in paitents with type 2 diabetes sitaglipin phospate, a dipeptidyl peptidase 4 (DPP-4) inhibitor, and metformin hydrochloride a member of the biguanide class.